1.
Unilateral retinopathy in a patient with diabetes and coronary heart disease.
Abalem, MF, Eagle, KA, Rao, RC
BMJ (Clinical research ed.). 2018;:k1703
2.
[Patogenetic therapy of patients with diabetes mellitus type 2 and cerebral vascular insufficiency].
Kamchatnov, PR, Karalkin, AV, Chugunov, AV, Kabanov, AA, Bassé, DA, Mikhaĭlova, NA, Umarova, KhIa, Boĭko, AN
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2008;(3):18-23
Abstract
Effectiveness of halidor preparation was assessed in a randomized open 8-weeks study in 44 patients with diabetes mellitus type 2 and chronic cerebral blood circulation disorders. A control group included 15 patients with the same pathologies who did not receive halidor. Administration of halidor in doses 100 mg 3 times daily led to the improvement of clinical state in 32 (72,7%) patients that was confirmed by statistically better performance (p<0,05) on the neuropsychological tests: MMSE by 14,7%, clock-drawing test by 16,8%, the Schult test by 23,5%. The blood flow in middle and posterior cerebral arteries was increased by 21 and 23%, respectively (p<0,05), and the vascular tonus was reduced. The possibility of halidor administration to patients with diabetes mellitus with concomitant chronic cerebral blood circulation disorders is discussed.
3.
Keeping the diabetic heart healthy.
Harris, M, Wan, Q
Australian family physician. 2005;(6):441-5
Abstract
BACKGROUND Cardiovascular disease (CVD) is an important and preventable complication and major cause of death in diabetes. OBJECTIVE This article outlines the prevention and early detection of CVD in people with type 2 diabetes. DISCUSSION Diabetes is a major risk factor for CVD, both independently and because it tends to occur in association with other behavioural and physiological risk factors. There is good evidence that careful control of these risk factors can significantly delay the development of heart disease, and that this is possible to achieve in general practice. Key interventions are smoking cessation; diet and physical activity; targeted use of medications to achieve glycaemic, blood pressure and lipid control; and aspirin. Interventions require a whole practice approach involving practice staff, practice systems and links with other care providers.